MWN117
/ Minwei Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 18, 2026
Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Shanghai Minwei Biotechnology Co., Ltd
New P1 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1